Trial site
Eye Clinic of Wisconsin
Wausau, Wisconsin 54403, United StatesNot linked to an institution yet
The trials here
What the 13 trials at this site are about, from their registry records.
- Phase
- Phase 311 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting8 trials
- Recruiting4 trials
- Not yet recruiting1 trial
- Lead sponsor
- 4D Molecular Therapeutics3 trials
- Kodiak Sciences Inc3 trials
- Jaeb Center for Health Research2 trials
- Annexon, Inc.1 trial
- EyeBiotech Ltd.1 trial
- and 3 more
Running trials
Recruiting
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
NCT07867080· Phase 3· 4D Molecular Therapeutics· Source
Contact: 4DMT Patient Advocacy
Recruiting
A Study in Adults With Geographic Atrophy
NCT07606365· Phase 2· Sitala Bio LTD· Source
Contact: Deepak Sambhara (principal investigator)
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
NCT07440225· Phase 2/3· EyeBiotech Ltd.· Source
Contact: Study Coordinator
Active, not recruiting
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
NCT07449923· Phase 3· EyePoint Pharmaceuticals, Inc.· Source
Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
NCT06990399· Phase 3· Kodiak Sciences Inc· Source
Contact: Kodiak Sciences Inc
Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
NCT07064759· Phase 3· 4D Molecular Therapeutics· Source
Contact: 4DMT Patient Advocacy
Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
NCT06996080· Phase 3· Kodiak Sciences Inc· Source
Contact: Kodiak Sciences Inc
Active, not recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
NCT06864988· Phase 3· 4D Molecular Therapeutics· Source
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK
NCT06556368· Phase 3· Kodiak Sciences Inc· Source
Active, not recruiting
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
NCT06510816· Phase 3· Annexon, Inc.· Source
Active, not recruiting
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration
NCT06223958· Phase 3· Ocular Therapeutix, Inc.· Source
Active, not recruiting
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
NCT05904028· Phase 3· Jaeb Center for Health Research· Source
Active, not recruiting
Fenofibrate for Prevention of DR Worsening
NCT04661358· Phase 3· Jaeb Center for Health Research· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error